Pharmaceuticals
Fecal Calprotectin Test Market

Fecal Calprotectin Test Market Size, Share, Trends, and Growth Forecast 2025 - 2032

Fecal Calprotectin Test Market by Technique (Enzyme-linked Immnunoabsorbent Assay, Enzyme Fluroimmunoassay, Others), by Indication (Inflammatory Bowel Disease (IBD), Irritable Bowel Syndrome (IBS), Others), by End-user, by Regional Analysis for 2025 - 2032

ID: PMRREP35197

April 2025

180 Pages

Author : Vaishnavi Patil

Healthcare

Market Dynamics

Driver - Growing Demand for Subscription-Based Diagnostic Services

Adopting subscription-based diagnostic services for fecal calprotectin testing is transforming chronic disease management, particularly for inflammatory bowel disease (IBD) patients. These services provide monthly or quarterly at-home test kits, enabling patients to track their inflammatory markers without frequent hospital visits. By integrating with telehealth platforms, subscription-based models allow seamless remote consultations, where gastroenterologists can analyze test results, detect early signs of flare-ups, and adjust treatment strategies in real time.

This proactive approach enhances patient convenience and reduces the burden on healthcare facilities, lowering emergency hospital admissions due to undiagnosed disease progression. Additionally, AI-powered dashboards are now integrated into these services and offer qualitative data for trend analysis of inflammation levels and predictive insights for personalized disease management.

Restraints - Variability in Sample Collection and Handling

Variability in stool sample collection and handling presents a significant challenge in the adoption of fecal calprotectin testing, as improper collection techniques can lead to inaccurate results, reducing the test reliability. Unlike blood or urine samples, stool consistency and composition can vary significantly among patients, affecting calprotectin concentration measurements. Factors such as diet, hydration levels, and transit time in the gut can alter the sample composition, making standardization difficult. Additionally, patients struggle with proper sample collection, leading to contamination, insufficient sample volume, or degradation of biomarkers before laboratory analysis.

Improper storage and transportation further exacerbate this issue. Since fecal calprotectin is a protein susceptible to degradation, delays in sample processing or exposure to temperature fluctuations can result in false-negative or misleading results. This inconsistency undermines physician confidence in the test, prompting some healthcare providers to favor more invasive diagnostic method such as endoscopy. Moreover, laboratory discrepancies in extraction protocols and analysis methods create further variability, limiting the widespread acceptance of fecal calprotectin testing as a diagnostic standard.

Get Your CustomizationGet Your Customization

Category Wise Insights

Technique Insights

Enzyme-linked immunosorbent assay (ELISA) leads the technique segment in the fecal calprotectin test market as a service-based market due to its high sensitivity, cost-effectiveness, and ability to handle large sample volumes efficiently. ELISA offers a standardized and automated approach, making it the preferred choice for diagnostic laboratories and service providers. Unlike lateral flow assays, which provides qualitative or semi-quantitative results, ELISA delivers precise and reproducible quantitative measurements of fecal calprotectin levels, improving diagnostic accuracy for inflammatory bowel diseases (IBD). Furthermore, ELISA-based fecal calprotectin tests are compatible with high-throughput screening, enabling service providers to process multiple samples simultaneously, reducing turnaround time and operational costs.

Indication Insights

Inflammatory bowel disease (IBD) leads the indication segment in the fecal calprotectin test market as a service-based market due to its growing global prevalence and the need for non-invasive diagnostic and monitoring solutions. Unlike irritable bowel syndrome (IBS) or other gastrointestinal disorders, IBD, comprising Crohn’s disease and ulcerative colitis requires frequent disease activity assessment to guide treatment decisions. Fecal calprotectin testing is a preferred option as it differentiates between inflammatory and non-inflammatory conditions, reducing unnecessary endoscopic procedures.

Additionally, IBD management relies on continuous monitoring to evaluate treatment efficacy and predict disease flares, making fecal calprotectin testing a cost-effective and patient-friendly alternative to repeated invasive tests.

fecal calprotectin test market insights and key trends

Regional Insights

North America Fecal Calprotectin Test Market Trends

North America dominates the fecal calprotectin test market as a service-based industry due to its advanced healthcare infrastructure, high disease prevalence, and increasing reliance on diagnostic outsourcing. The region has a well-established network of reference laboratories and diagnostic service providers, allowing for widespread accessibility to fecal calprotectin testing without the need for in-house hospital diagnostics. The rising incidence of inflammatory bowel diseases (IBD), including Crohn’s disease and ulcerative colitis has driven demand for non-invasive biomarkers, with fecal calprotectin emerging as a preferred diagnostic tool.

According to the CDC in 2024, IBD affected approximately three million adults in the U.S., creating a strong need for outsourcing diagnostic services. Additionally, favorable reimbursement policies from private and public insurers encourage clinicians to recommend fecal calprotectin tests, boosting service-based testing volumes.

Europe Fecal Calprotectin Test Market Trends

Europe is the second-leading region in the fecal calprotectin test market due to a combination of strong healthcare infrastructure, high prevalence of inflammatory bowel diseases (IBD), and government-backed reimbursement policies. Countries such as Germany, the UK, and France have well-established diagnostic services enabling the widespread adoption of fecal calprotectin testing, particularly in primary and secondary healthcare settings.

The growing burden of Crohn’s disease and ulcerative colitis in Europe, with an estimated prevalence of over 3.4 million cases drives demand for non-invasive biomarkers such as fecal calprotectin, reducing the need for more invasive diagnostic procedures such as endoscopy. Additionally, Europe's stringent clinical guidelines, such as those issued by the European Crohn’s and Colitis Organization (ECCO), encourage the routine use of fecal calprotectin tests for monitoring disease progression, further accelerating market adoption.

Asia Pacific Fecal Calprotectin Test Market Trends

Asia Pacific is rapidly emerging as a key market for fecal calprotectin testing services, driven by the increasing prevalence of gastrointestinal disorders and the rising burden of inflammatory bowel disease (IBD). The shift towards early disease detection and non-invasive diagnostics has fueled demand for fecal calprotectin tests, particularly in urban centers where healthcare accessibility is improving.

Japan and South Korea lead in advanced diagnostic services with well-established laboratory infrastructure and government-supported insurance schemes covering biomarker-based tests. Meanwhile, India and Southeast Asian countries are experiencing strong growth due to the expansion of private diagnostic labs offering cost-effective fecal calprotectin testing as a service. The increasing adoption of outsourced laboratory testing models in hospitals and clinics has further propelled market expansion, enabling faster and more efficient diagnostics.

Request Free sampleRequest Free sample

Competitive Landscape

The global fecal calprotectin test market is highly competitive, with key players focusing on expanding laboratory networks, automation, and AI-driven diagnostics. Strategic collaborations between hospitals and third-party labs continue to shape market dynamics, making innovation and cost-efficiency a key differentiator in this evolving landscape.

Key Industry Developments:

In November 2023, new guidelines from the American Gastroenterological Association meant that people living with Crohn’s disease needed fewer invasive procedures.
In May 2023, Epitope Diagnostics successfully developed a comprehensive panel of test manuals and user-friendly devices specifically designed for easy fecal sample collection and extraction. Their commitment to this field enabled them to offer reliable and efficient solutions for gastrointestinal testing.

Companies Covered in Fecal Calprotectin Test Market

Epitope Diagnostics Inc.
Hycult Biotech
Actim
OPERON
Svar Life Science
BÜHLMANN
DRG International Inc.
ALPCO
Diazyme Laboratories
Thermo Fisher Scientific Inc.
Others

Frequently Asked Questions

The global fecal calprotectin test market is estimated to increase from US$4,728.3 Mn in 2025 to US$9,623.7 Mn in 2032.

The increasing incidence of inflammatory bowel disease (IBD), Crohn’s disease, and ulcerative colitis is a major driver. Over 10 million people worldwide are affected by IBD, which fuels the need for non-invasive diagnostics such as fecal calprotectin testing.

The market is projected to record a CAGR of 8.9% during the forecast period from 2025 to 2032.

The growing demand for convenient and patient-friendly diagnostics is creating opportunities for home-based fecal sample collection kits. Medical companies are investing in telehealth integration and AI-driven analysis to enhance accessibility.

The key players in the fecal calprotectin market include Epitope Diagnostics Inc., Hycult Biotech, Actim, OPERON, Svar Life Science, and others.

Top-Down Market Sizing	Bottom-Up Market Sizing
Universe Definition: Total global/regional market identification	Unit Economics: Average transaction values, purchase frequencies, customer lifecycle
Segmentation Filters: Geographic, demographic, and behavioral constraints	Customer Segmentation: Detailed buyer persona development and sizing
Market Share Analysis: Competitive landscape assessment and share allocation	Penetration Analysis: Market penetration rates by segment and geography
Growth Rate Application: Historical trends and forward-looking growth assumptions	Scaling Methodology: Extrapolation techniques with confidence intervals

Interested in this report?

Request customization, ask for expert consulting, access a sample report, or simply express your interest—our team will assist you with the right insights and solutions.

Request Custom VersionRequest Custom Version

Clients

Media Citation

Get In Touch

Loading page data

Please wait a moment

Executive Summary
1. Global Fecal Calprotectin Test Market Snapshot, 2025 and 2032
2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
3. Key Market Trends
4. Future Market Projections
5. Premium Market Insights
6. Industry Developments and Key Market Events
7. PMR Analysis and Recommendations
Market Overview
1. Market Scope and Definition
2. Market Dynamics
  1. Drivers
  2. Restraints
  3. Opportunity
  4. Challenges
  5. Key Trends
3. Macro-Economic Factors
  1. Global Sectorial Outlook
  2. Global GDP Growth Outlook
4. COVID-19 Impact Analysis
5. Forecast Factors - Relevance and Impact
Value Added Insights
1. Regulatory Landscape
2. Technique Adoption Analysis
3. Value Chain Analysis
4. Key Deals and Mergers
5. PESTLE Analysis
6. Porter’s Five Force Analysis
Global Fecal Calprotectin Test Market Outlook:
1. Key Highlights
  1. Market Size (US$ Mn) and Y-o-Y Growth
  2. Absolute $ Opportunity
2. Market Size (US$ Mn) Analysis and Forecast
  1. Historical Market Size (US$ Mn) Analysis, 2019-2024
  2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
3. Global Fecal Calprotectin Test Market Outlook: Technique
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By Technique, 2019 - 2024
  3. Current Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025 - 2032
    1. Enzyme-linked Immunosorbent Assay
    2. Enzyme Fluroimmunoassay
    3. Immunochromatography
    4. Point-of-care tests
    5. Others
  4. Market Attractiveness Analysis: Technique
4. Global Fecal Calprotectin Test Market Outlook: Indication
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By Indication, 2019 - 2024
  3. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
    1. Inflammatory Bowel Disease (IBD)
    2. Irritable Bowel Syndrome (IBS)
    3. Colorectal Cancer
    4. Infections
    5. Others
  4. Market Attractiveness Analysis: Indication
5. Global Fecal Calprotectin Test Market Outlook: End User
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By End User, 2019 - 2024
  3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
    1. Hospitals & Clinics
    2. Diagnostic Laboratories
    3. Research Institutes
    4. Gastroenterology Centers
  4. Market Attractiveness Analysis: End User
Global Fecal Calprotectin Test Market Outlook: Region
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Region, 2019 - 2024
3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2025 - 2032
  1. North America
  2. Europe
  3. East Asia
  4. South Asia and Oceania
  5. Latin America
  6. Middle East & Africa
4. Market Attractiveness Analysis: Region
North America Fecal Calprotectin Test Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
  1. By Country
  2. By Technique
  3. By Indication
  4. By End User
3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
  1. U.S.
  2. Canada
4. Current Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025 - 2032
  1. Enzyme-linked Immunosorbent Assay
  2. Enzyme Fluroimmunoassay
  3. Immunochromatography
  4. Point-of-care tests
  5. Others
5. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
  1. Inflammatory Bowel Disease (IBD)
  2. Irritable Bowel Syndrome (IBS)
  3. Colorectal Cancer
  4. Infections
  5. Others
6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
  1. Hospitals & Clinics
  2. Diagnostic Laboratories
  3. Research Institutes
  4. Gastroenterology Centers
7. Market Attractiveness Analysis
Europe Fecal Calprotectin Test Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
  1. By Country
  2. By Technique
  3. By Indication
  4. By End User
3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
  1. Germany
  2. France
  3. U.K.
  4. Italy
  5. Spain
  6. Russia
  7. Türkiye
  8. Rest of Europe
4. Current Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025 - 2032
  1. Enzyme-linked Immunosorbent Assay
  2. Enzyme Fluroimmunoassay
  3. Immunochromatography
  4. Point-of-care tests
  5. Others
5. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
  1. Inflammatory Bowel Disease (IBD)
  2. Irritable Bowel Syndrome (IBS)
  3. Colorectal Cancer
  4. Infections
  5. Others
6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
  1. Hospitals & Clinics
  2. Diagnostic Laboratories
  3. Research Institutes
  4. Gastroenterology Centers
7. Market Attractiveness Analysis
East Asia Fecal Calprotectin Test Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
  1. By Country
  2. By Technique
  3. By Indication
  4. By End User
3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
  1. China
  2. Japan
  3. South Korea
4. Current Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025 - 2032
  1. Enzyme-linked Immunosorbent Assay
  2. Enzyme Fluroimmunoassay
  3. Immunochromatography
  4. Point-of-care tests
  5. Others
5. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
  1. Inflammatory Bowel Disease (IBD)
  2. Irritable Bowel Syndrome (IBS)
  3. Colorectal Cancer
  4. Infections
  5. Others
6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
  1. Hospitals & Clinics
  2. Diagnostic Laboratories
  3. Research Institutes
  4. Gastroenterology Centers
7. Market Attractiveness Analysis
South Asia & Oceania Fecal Calprotectin Test Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
  1. By Country
  2. By Technique
  3. By Indication
  4. By End User
3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
  1. India
  2. Southeast Asia
  3. ANZ
  4. Rest of South Asia & Oceania
4. Current Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025 - 2032
  1. Enzyme-linked Immunosorbent Assay
  2. Enzyme Fluroimmunoassay
  3. Immunochromatography
  4. Point-of-care tests
  5. Others
5. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
  1. Inflammatory Bowel Disease (IBD)
  2. Irritable Bowel Syndrome (IBS)
  3. Colorectal Cancer
  4. Infections
  5. Others
6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
  1. Hospitals & Clinics
  2. Diagnostic Laboratories
  3. Research Institutes
  4. Gastroenterology Centers
7. Market Attractiveness Analysis
Latin America Fecal Calprotectin Test Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
  1. By Country
  2. By Technique
  3. By Indication
  4. By End User
3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
  1. Brazil
  2. Mexico
  3. Rest of Latin America
4. Current Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025 - 2032
  1. Enzyme-linked Immunosorbent Assay
  2. Enzyme Fluroimmunoassay
  3. Immunochromatography
  4. Point-of-care tests
  5. Others
5. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
  1. Inflammatory Bowel Disease (IBD)
  2. Irritable Bowel Syndrome (IBS)
  3. Colorectal Cancer
  4. Infections
  5. Others
6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
  1. Hospitals & Clinics
  2. Diagnostic Laboratories
  3. Research Institutes
  4. Gastroenterology Centers
7. Market Attractiveness Analysis
Middle East & Africa Fecal Calprotectin Test Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
  1. By Country
  2. By Technique
  3. By Indication
  4. By End User
3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
  1. GCC Countries
  2. Egypt
  3. South Africa
  4. Northern Africa
  5. Rest of Middle East & Africa
4. Current Market Size (US$ Mn) Analysis and Forecast, By Technique, 2025 - 2032
  1. Enzyme-linked Immunosorbent Assay
  2. Enzyme Fluroimmunoassay
  3. Immunochromatography
  4. Point-of-care tests
  5. Others
5. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2025 - 2032
  1. Inflammatory Bowel Disease (IBD)
  2. Irritable Bowel Syndrome (IBS)
  3. Colorectal Cancer
  4. Infections
  5. Others
6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
  1. Hospitals & Clinics
  2. Diagnostic Laboratories
  3. Research Institutes
  4. Gastroenterology Centers
7. Market Attractiveness Analysis
Competition Landscape
1. Market Structure
  1. Competition Intensity Mapping By Market
  2. Competition Dashboard
2. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  1. Epitope Diagnostics Inc.
    1. Overview
    2. Segments and Techniques
    3. Key Financials
    4. Market Developments
    5. Market Strategy
  2. Hycult Biotech
  3. Actim
  4. OPERON
  5. Svar Life Science
  6. BÜHLMANN
  7. DRG International Inc.
  8. ALPCO
  9. Diazyme Laboratories
  10. Thermo Fisher Scientific Inc.
  11. Others
Appendix
1. Research Methodology
2. Research Assumptions
3. Acronyms and Abbreviations

Global Market Attribute	Key Insights
Market Size (2025E)	US$ 4,728.3 Mn
Market Value Forecast (2032F)	US$ 9,623.7 Mn
Projected Growth (CAGR 2025 to 2032)	8.9%
Historical Market Growth (CAGR 2019 to 2024)	7.5%

Report Attribute	Details
Historical Data/Actuals	2019 - 2024
Forecast Period	2025 - 2032
Market Analysis Units	Value: US$ Mn
Geographical Coverage	North America Europe East Asia South Asia and Oceania Middle East and Africa Latin America
Segmental Coverage	Technique Indication End-user Region
Competitive Analysis	Epitope Diagnostics Inc. Hycult Biotech Actim OPERON Svar Life Science BÜHLMANN DRG International Inc. ALPCO Diazyme Laboratories Thermo Fisher Scientific Inc. Others
Report Highlights	Market Forecast and Trends Growth Factors and Challenges Strategic Growth Initiatives Future Opportunities and Revenue Pockets
Customization and Pricing	Available upon request

Global Market Attribute	Key Insights
Market Size (2025E)	US$ 4,728.3 Mn
Market Value Forecast (2032F)	US$ 9,623.7 Mn
Projected Growth (CAGR 2025 to 2032)	8.9%
Historical Market Growth (CAGR 2019 to 2024)	7.5%

Report Attribute	Details
Historical Data/Actuals	2019 - 2024
Forecast Period	2025 - 2032
Market Analysis Units	Value: US$ Mn
Geographical Coverage	North America Europe East Asia South Asia and Oceania Middle East and Africa Latin America
Segmental Coverage	Technique Indication End-user Region
Competitive Analysis	Epitope Diagnostics Inc. Hycult Biotech Actim OPERON Svar Life Science BÜHLMANN DRG International Inc. ALPCO Diazyme Laboratories Thermo Fisher Scientific Inc. Others
Report Highlights	Market Forecast and Trends Growth Factors and Challenges Strategic Growth Initiatives Future Opportunities and Revenue Pockets
Customization and Pricing	Available upon request

Fecal Calprotectin Test Market Size, Share, Trends, and Growth Forecast 2025 - 2032

Fecal Calprotectin Test Market by Technique (Enzyme-linked Immnunoabsorbent Assay, Enzyme Fluroimmunoassay, Others), by Indication (Inflammatory Bowel Disease (IBD), Irritable Bowel Syndrome (IBS), Others), by End-user, by Regional Analysis for 2025 - 2032